Andere Sprachen GeneDx Holdings Corp.

Aktien

A3EEXG

US81663L2007

WGS

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 02.05.2024			% 5 Tage	% 1. Jan.
19,5 ^USD	-6,79 %		+74,57 %	+609,09 %

30.04.	Sektor-Update: Aktien des Gesundheitswesens am späten Nachmittag uneinheitlich	MT
30.04.	Top Mittagsgewinner	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Health Care Flat Amid Mixed Earnings -- Health Care Roundup	30.04.
Sector Update: Health Care Stocks Mixed Late Afternoon	30.04.
Top Midday Gainers	30.04.
GeneDx : 1Q 2024 Earnings Deck	29.04.
GeneDx Holdings Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	29.04.
GeneDx : Q1 2024 Earnings Presentation	29.04.
GeneDx Reports First Quarter 2024 Financial Results and Business Highlights	29.04.
GeneDx Holdings Corp. Updates Earnings Guidance for the Year 2024	29.04.
GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset	23.04.
Genedx Announces Partnership with Komodo Health to Expand Access to World?S Largest Rare Disease Dataset	23.04.
GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024	04.04.
GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of Genomics	14.03.
GeneDx to Participate in 44th Annual Cowen Health Care Conference	26.02.
Health Care Down on a Mixed Growth View -- Health Care Roundup	21.02.
Earnings Flash (WGS) GENEDX HOLDINGS Posts Q4 Revenue $57.4M	20.02.
GeneDx Holdings Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	20.02.
GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024	20.02.
GeneDx Holdings Corp. Provides Earnings Guidance for the Full Year of 2024	20.02.
GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024	01.02.
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	24.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen GeneDx Holdings Corp.

Aktien

A3EEXG

US81663L2007

WGS

Andere Sprachen

Filter